Navigation Links
Drugs in the pipeline: new therapies that could change treatment strategies
Date:4/15/2008

linical trial.

In the 16 patients evaluated so far, four have achieved either a partial or complete response with use of the novel agent AME-133v, said the studys lead investigator, Andres Forero, M.D., associate scientist at the University of Alabama, Birmingham, Comprehensive Cancer Center.

These first results suggest that AME-133v provides a mechanism of action that may be more potent and ultimately more effective than the treatments we have on hand for a subset of patients with this cancer, Forero said. Given these encouraging results, patients are currently being enrolled in a phase II study.

The majority of patients in this study either did not initially respond or relapsed after use of rituximab, the first monoclonal antibody therapy approved for use in lymphoma treatment.

AME-133v is a second-generation therapy that is believed to be a more specific treatment for follicular lymphoma in general, compared to rituximab, but is also thought to offer particular benefits for those patients who have a variant in the immune cells needed to attack the cancer, Forero says.

Monoclonal antibodies were the first successful targeted therapy for cancer, and we have now moved on to a whole new class of second generation antibodies for the treatment of many different lymphomas, Forero said. This is an exciting time.

Follicular lymphoma is a particularly difficult to treat subtype of non-Hodgkin lymphoma, which is a cancer that arises from white blood immune cells known as lymphocytes. Rituximab binds to CD20, a cell surface antigen expressed on almost all B-cell lymphomas as well as on normal B cells, and works to kill the cancer cell via a mechanism that is not yet understood.

Although treatment with rituximab as a single agent has resulted in significant responses in patients with almost every subtype of B-cell lymphoma, including follicular lymphoma, recent evidence has shown that some patients with effecto
'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... published in this week,s JAMA highlights the ... when considering how to treat patients. Written by Robert ... and chair of pediatrics at Boston University School of ... , the editorial examines results of a study published ... example of how doctors can often over-emphasize certain types ...
(Date:8/19/2014)... involved in multitasking and ways to train it have ... Institut universitaire de griatrie de Montral and the University ... predict the effectiveness of this training. Cooking while having ... or driving while listening to a radio show ... lives. Unfortunately, it decreases with age, which makes it ...
(Date:8/19/2014)... Kars4Kids , a national nonprofit organization ... partnership with New York State Senator Gustavo Rivera to ... The giveaway will take place in conjunction with Rivera’s ... August 22. , “With a mission focused on ... children for school with the necessary supplies is imperative,” ...
(Date:8/19/2014)... 2014 Top10BestSEOHosting.com has recently announced ... the recommended suppliers for the webmasters who want ... , According to the senior spokesman for Top10BestSEOHosting.com, ... affordable hosting products on the market and specializes ... variety of online deals when service plans are ...
(Date:8/19/2014)... August 19, 2014 “ Inbox Blueprint ... course designed to provide users with the tools necessary ... marketing techniques and strategies. The course which was ... of excitement throughout the internet marketing world. The commotion ... HonestyFirstReviews.com's Tiffany Hendricks prompting an updated review of the ...
Breaking Medicine News(10 mins):Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Targeted brain training may help you multitask better 2Health News:Backpack Giveaway Kars4Kids Partners with New York State Senator Gustavo Rivera to Prepare Bronx Students for New School Year 2Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2Health News:Anik Singal’s “Inbox Blueprint” Review Released By HonestyFirstReviews.com 2
... , LOS ANGELES, July 28 Interested ... musician? California Cryobank (CCB) , the nation,s leading ... feature, which allows clients to view online photos of celebrities ... "The number one client question we get is ,Who does ...
... for Eligard(R) Sales and Adjusted EBITDA , , VANCOUVER, ... ; TSX: QLT) ("QLT" or the "Company") today reported financial ... specified otherwise, all amounts are in U.S. dollars and in ... another strong financial quarter, with robust Eligard(R) sales of $67.6 ...
... , , CINCINNATI, July 28 ... laser vision correction services under the Lasik Plus ((R)) brand, today ... ended June 30, 2009. , , Second ... the second quarter of 2008) , , ...
... , Nasdaq-Listed Biopharmaceutical Company Focusing ... to Benefit Underserved Patient Populations , , ... Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin ... TPTX ), today announced that they have entered into a ...
... , , GAINESVILLE, Fla., ... its stance on electronic cigarette products last week, the administration only tested ... brands is that they are made by the two manufacturers currently suing ... "In comparison to the toxins and carcinogens contained in tobacco ...
... WILMINGTON, Delaware, July 28 According to a new ... ( http://www.marketsandmarkets.com ), the total drug-device,combination market is expected to ... market will account for nearly 30.9% of the total revenues.,The ... from 2009 to 2014. , Browse ...
Cached Medicine News:Health News:California Cryobank Introduces Celebrity Look-a-Likes for Sperm Donors 2Health News:QLT Announces Second Quarter Results for 2009 2Health News:QLT Announces Second Quarter Results for 2009 3Health News:QLT Announces Second Quarter Results for 2009 4Health News:QLT Announces Second Quarter Results for 2009 5Health News:QLT Announces Second Quarter Results for 2009 6Health News:QLT Announces Second Quarter Results for 2009 7Health News:QLT Announces Second Quarter Results for 2009 8Health News:QLT Announces Second Quarter Results for 2009 9Health News:QLT Announces Second Quarter Results for 2009 10Health News:QLT Announces Second Quarter Results for 2009 11Health News:QLT Announces Second Quarter Results for 2009 12Health News:QLT Announces Second Quarter Results for 2009 13Health News:QLT Announces Second Quarter Results for 2009 14Health News:QLT Announces Second Quarter Results for 2009 15Health News:QLT Announces Second Quarter Results for 2009 16Health News:QLT Announces Second Quarter Results for 2009 17Health News:LCA-Vision Reports Second Quarter Financial Results 2Health News:LCA-Vision Reports Second Quarter Financial Results 3Health News:LCA-Vision Reports Second Quarter Financial Results 4Health News:LCA-Vision Reports Second Quarter Financial Results 5Health News:LCA-Vision Reports Second Quarter Financial Results 6Health News:LCA-Vision Reports Second Quarter Financial Results 7Health News:LCA-Vision Reports Second Quarter Financial Results 8Health News:LCA-Vision Reports Second Quarter Financial Results 9Health News:LCA-Vision Reports Second Quarter Financial Results 10Health News:LCA-Vision Reports Second Quarter Financial Results 11Health News:LCA-Vision Reports Second Quarter Financial Results 12Health News:LCA-Vision Reports Second Quarter Financial Results 13Health News:LCA-Vision Reports Second Quarter Financial Results 14Health News:Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement 2Health News:Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement 3Health News:Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement 4Health News:Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement 5Health News:Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement 6
(Date:8/19/2014)... , Aug. 19, 2014  The Alabama Supreme Court, ... patients can sue drug makers who mislead doctors into believing ... side‑effects.  The case is Weeks v. Wyeth, and the decision ... in that same case last year. Heninger Garrison Davis attorneys ... the patient in the case, Danny Weeks . ...
(Date:8/19/2014)... 2014 Minimally Invasive Devices Inc. (MID), a ... announced today that Mitsubishi Corporation has formally agreed to ... in Japan . MID anticipates that ... Japan in the second half of 2015. ... for Karl Storz GMBH & Co. (endoscopic instruments and ...
(Date:8/19/2014)...  As power morcellator lawsuits continue to mount ... notes that women in need of fibroid removal ... options that do not involve the use of ... report published by The Wall Street Journal on ... mini-laparotomy and vaginal hysterectomy. Non-surgical options for shrinking ...
Breaking Medicine Technology:Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3
... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today ... credit facilities of its wholly owned subsidiary Valeant ... by the Company.  The proposed $1.7 billion senior ... a $200 million revolving facility and a $1.5 ...
... 20, 2011 – Ingenuity® Systems, a leading ... life science researchers, today announced the addition ... from miRecords , plus thousands of ... peer-reviewed literature. The newly added content supplements ...
Cached Medicine Technology:Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities 2Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA 2
... The Brasseler USA™ Battery Packs contain ... age have a great impact upon battery ... is necessary. Any deviation from these recommendations ... are sensitive to heat. Any exposure of ...
Pneumatic High-speed Drill, Throttleless, 90k Rpm, Microaire Connector....
Pneumatic foot surgical oscillating saw, 24k cpm, available with various hose connector styles....
... Motor Module, without throttle (MicroAire hose connector). ... attachments., ,1050-100 model requires 10ft. ... MicroAire connector. Also requires 9100-000 Foot Control ... hose 9013-000, or existing hose with Linvatec/Hall ...
Medicine Products: